DASH vs TENX · P/E 76, rev $13.72B vs P/E 3.4, $24.1M cap
DoorDash, Inc. Class A Common Stock (DASH) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported TENX revenue for 2025-09-30 was $0. Net income was -$37.1M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the DASH and TENX stock pages for the full models.
Not investment advice.